Korean Circulation Journal

The Korean Society of Cardiology (대한심장학회)
권호 표지
DOI QR코드

DOI QR Code

Pre-Treatment with Statins for Coronary Intervention: Pleiotropy of Statins or Effect of LDL-cholesterol Reduction?

  • Habon, Tamas (1st Department of Medicine, Division of Cardiology, University of Pecs, Medical Center) ;
  • Toth, Kalman (1st Department of Medicine, Division of Cardiology, University of Pecs, Medical Center)
  • Received : 2016.05.11
  • Accepted : 2016.07.01
  • Published : 2016.07.30
⟨ Previous Next ⟩

Abstract

Keywords

References

  1. Wang CY, Liu PY, Liao JK. Pleiotropic effects of statin therapy: molecular mechanisms and clinical results. Trends Mol Med 2008;14:37-44. https://doi.org/10.1016/j.molmed.2007.11.004
  2. Rosenson RS. Statin therapy: new therapy for cardiac microvascular dysfunction. Eur Heart J 2003;24:1993-4. https://doi.org/10.1016/j.ehj.2003.08.005
  3. Szapary L, Horvath B, Marton Z, et al. Short-term effect of low-dose atorvastatin on haemorrheological parameters, platelet aggregation and endothelial function in patients with cerebrovascular disease and hyperlipidaemia. CNS Drugs 2004;18:165-72. https://doi.org/10.2165/00023210-200418030-00003
  4. Eisen A, Leshem-Lev D, Yavin H, et al. Effect of High Dose Statin Pretreatment on Endothelial Progenitor Cells After Percutaneous Coronary Intervention (HIPOCRATES Study). Cardiovasc Drugs Ther 2015;29:129-35. https://doi.org/10.1007/s10557-015-6575-8
  5. Lee BK, Koo BK, Nam CW, et al. Does pretreatment with high dose atorvastatin prevent microvascular dysfunction after percutaneous coronary intervention in patients with acute coronary syndrome? Korean Circ J 2016;46:472-80. https://doi.org/10.4070/kcj.2016.46.4.472
  6. Pasceri V, Patti G, Nusca A, Pristipino C, Richichi G, Di Sciascio G: ARMYDA Investigators. Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention: results from the ARMYDA (Atorvastatin for Reduction of Myocardial Damage during Angioplasty) study. Circulation 2004;110:674-8. https://doi.org/10.1161/01.CIR.0000137828.06205.87
  7. Briguori C, Visconti G, Focaccio A, et al. Novel approaches for preventing or limiting events (NAPLES) II trial: impact of a single high loading dose of atorvastatin on periprocedural myocardial infarction. J Am Coll Cardiol 2009;54:2157-63. https://doi.org/10.1016/j.jacc.2009.07.005
  8. Fearon WF, Balsam LB, Farouque HM, et al. Novel index for invasively assessing the coronary microcirculation. Circulation 2003;107:3129-32. https://doi.org/10.1161/01.CIR.0000080700.98607.D1
  9. Fujii K, Kawasaki D, Oka K, et al. The impact of pravastatin pretreatment on periprocedural microcirculatory damage in patients undergoing percutaneous coronary intervention. JACC Cardiovasc Interv 2011;4:513-20. https://doi.org/10.1016/j.jcin.2011.02.005
  10. Eagle KA, Chopra V. Statins before coronary procedures a new indication for an old friend. J Am Coll Cardiol 2010;56:1110-2. https://doi.org/10.1016/j.jacc.2010.04.022
  11. Tamai O, Matsuoka H, Itabe H, Wada Y, Kohno K, Imaizumi T. Single LDL apheresis improves endothelium-dependent vasodilatation in hypercholesterolemic humans. Circulation 1997;95:76-82. https://doi.org/10.1161/01.CIR.95.1.76
  12. Jarcho JA, Keaney JF Jr. Proof that lower is better--LDL cholesterol and IMPROVE-IT. N Engl J Med 2015;372:2448-50. https://doi.org/10.1056/NEJMe1507041